ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →

← November 18, 2026 edited reader edition

THE ARISING · Longevity & Healthspan

FDA Cleared Updated Cleerly Software to Measure Coronary Plaque

The company drew on a more diverse registry cohort to update its AI model. That is not the same as proving that the update improves patient outcomes.

Coronary CT angiography can reveal plaque in the heart’s arteries, including plaque that does not severely narrow them. Cleerly’s software helps trained clinicians identify, characterize and quantify that buildup on scans they are already evaluating. The software does not replace a clinician’s interpretation.

The FDA issued separate 510(k) clearances for an updated Cleerly LABS and the Cleerly Plaque module on July 29, 2026. Cleerly announced the clearances on October 30 and said it planned to make the update available to customers in November.

The company says the updated plaque model draws on a CONFIRM2 registry cohort of 6,550 people from 46 countries, about half of them women. That describes the registry cohort used to inform the model, not necessarily the entire training set. Broader representation is valuable, but it does not show by itself that the update performs equally well across groups. The clearance is not a green light for population screening or evidence that using this version prevents heart attacks. The next useful test is whether the measurements improve treatment decisions and outcomes in routine care.

Plaque measurements and narrowing answer related but different questions. One describes the buildup in the artery wall; the other describes how much space remains for blood to flow. Software can help report both from an existing scan, but the clinical question is still what to do with that information. A useful evaluation would distinguish better agreement between readers from a change in preventive care, and then ask whether the change benefits patients.

FDA clearance: Cleerly LABS · FDA clearance: Cleerly Plaque · Cleerly announcement

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗